Geron raises revenue guidance to $230–$240 million
Geron raised revenue guidance to $230—$240 million, citing strong growth. The company also said profitability is in sight, while it expands into deeper community penetration and international markets and advances a pivotal myelofibrosis trial with regulatory engagement.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.